Found: 5
Select item for more details and to access through your institution.
Tolerability of Aminosalicylates in Inflammatory Bowel Disease.
- Published in:
- BioDrugs, 2001, v. 15, n. 5, p. 339, doi. 10.2165/00063030-200115050-00005
- By:
- Publication type:
- Article
C[sub 2] Monitoring Strategy for Optimising Cyclosporin Immunosuppression from the Neoral[sup ®] Use of trade names is for identification purposes only, and does not imply endorsement. Formulation.
- Published in:
- BioDrugs, 2001, v. 15, n. 5, doi. 10.2165/00063030-200115050-00001
- By:
- Publication type:
- Article
Pathophysiology of Immune-Mediated (Type 1) Diabetes Mellitus: Potential for Immunotherapy.
- Published in:
- BioDrugs, 2001, v. 15, n. 5, p. 291, doi. 10.2165/00063030-200115050-00002
- By:
- Publication type:
- Article
Prophylaxis and Treatment of Influenza Virus Infection.
- Published in:
- BioDrugs, 2001, v. 15, n. 5, p. 303, doi. 10.2165/00063030-200115050-00003
- By:
- Publication type:
- Article
Immunological Aspects of Alzheimer's Disease: Therapeutic Implications.
- Published in:
- BioDrugs, 2001, v. 15, n. 5, p. 325, doi. 10.2165/00063030-200115050-00004
- By:
- Publication type:
- Article